SCHEMBL16218985

SCHEMBL16218985

COc1c(C)ccc2c1C(=O)OC2CO

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.54
HPGD P15428 3/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
ALDH1A1 P00352 5/20 0.48
KMT2A Q03164 3/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MAPT P10636 4/20 0.46
GAA P10253 2/20 0.46
TSHR P16473 1/20 0.46
ALPL P05186 1/20 0.46
POLB P06746 1/20 0.46
ALPG P10696 1/20 0.46
ALOX12 P18054 1/20 0.46
PLAA Q9Y263 1/20 0.46
LMNA P02545 1/20 0.45
HSD17B10 Q99714 3/20 0.42
CYP2C19 P33261 1/20 0.39
CES2 O00748 1/20 0.38
ATM Q13315 1/20 0.37
POLL Q9UGP5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14970288 0.85 KDM4E (0.73) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL16218986 0.81 KDM4E (0.44) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL16870307 0.78 POLL (0.43) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL14970282 0.77 HPGD (0.51) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL14965967 0.77 HPGD (0.51) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL18205617 0.76 POLL (0.41) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL16870478 0.76 POLL (0.41) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL16870316 0.74 KDM4E (0.46) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL18205611 0.74 KDM4E (0.43) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A
SCHEMBL16870436 0.74 KDM4E (0.43) KDM4EHPGDSMN1; SMN2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9505733-B2 Single step enantioselective process for the preparation of 3-substituted chiral phthalides COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-11-29 US disclosed
US-20150299154-A1 SINGLE STEP ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED CHIRAL PHTHALIDES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-10-22 US disclosed
US-9073887-B2 Single step enantioselective process for the preparation of 3-substituted chiral phthalides COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-07-07 US disclosed
US-20140330027-A1 SINGLE STEP ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED CHIRAL PHTHALIDES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140330027-A1 SINGLE STEP ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED CHIRAL PHTHALIDES PPOX, NFE2L2, CBR1 KDM4E 805/4885HPGD 2135/4885SMN1; SMN2 3151/4885
US-20150299154-A1 SINGLE STEP ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED CHIRAL PHTHALIDES PPOX, NFE2L2, CBR1 KDM4E 805/4885HPGD 2135/4885SMN1; SMN2 3151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.